CVALF (Covalon Technologies) Total Deposits

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CVALF Covalon Technologies Ltd CVALF
83 GF Score
Price $1.48
GF Value $1.54
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Covalon Technologies Total Deposits?

Total Deposits only applies to banks.

CVALF
83GF Score
Covalon Technologies Ltd CVALF
Total Deposits is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Covalon Technologies (CVALF) Overvalued in 2026?

Based on GuruFocus' analysis, Covalon Technologies stock appears to be undervalued. The current stock price of $1.48 is trading 4.2% below its estimated GF Value™ of $1.54. GuruFocus considers Covalon Technologies to be Fairly Valued.

Key valuation signals for CVALF:

  • Total Deposits:
  • GF Value™: $1.54 vs. price of $1.48 (4.2% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Covalon Technologies Business Description

Other Exchanges COV:Canada
Address 1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
83GF Score

Get the complete analysis for CVALF

Total Deposits is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.48
Price
$1.54
GF Value